↓ Skip to main content

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
Published in
Journal of Experimental & Clinical Cancer Research, June 2020
DOI 10.1186/s13046-020-01603-0
Pubmed ID
Authors

Xiaoling Wu, Weijie Ma, Chengjie Mei, Xi Chen, Ye Yao, Yingyi Liu, Xian Qin, Yufeng Yuan

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 14%
Student > Bachelor 6 12%
Other 4 8%
Student > Master 3 6%
Researcher 2 4%
Other 6 12%
Unknown 21 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 22%
Agricultural and Biological Sciences 3 6%
Medicine and Dentistry 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Unspecified 2 4%
Other 4 8%
Unknown 24 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2022.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,121
of 2,382 outputs
Outputs of similar age
#265,817
of 433,033 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#24
of 63 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,033 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.